Over 2 decades ago, the aldosterone antagonist eplerenone proved beneficial after MI complicated by left ventricular ...

Patients with acute MI were randomized in 1:1 fashion to receive spironolactone 25 mg daily (n = 3,537) or placebo (n = 3,525) following PCI, preferably with the Boston Scientific SYNERGY ...

Trichologist Kari Williams, Ph.D, explains that whether you're 25 or 55, seeing your hair disappear can feel ... can also ...

The treatment of acne ( Table I) [1,2,3,4,5,6] is based upon its severity (mild, moderate, severe) and the type(s) of lesion(s) present (noninflammatory, inflammatory, mixed). In general, the ...

It has some similarities to the potassium-sparing diuretic spironolactone ... treatment is initiated at 25 mg once daily and titrated to a target of 50 mg once daily within 4 weeks.

As people age, their hair often becomes thinner or more sparse. Pattern hair loss affects 85% of men according to the American Hair Loss Association and 50% of women according to Cleveland Clinic.

While the FDA hasn’t approved oral minoxidil for hair loss, clinical trials have shown it’s quite effective for hair growth at various doses (0.25 to 2.5 mg daily). Spironolactone. For those ...

No Difference in Primary Outcome CLEAR SYNERGY (OASIS 9) is a 2 x 2 randomized controlled trial of low-dose colchicine 0.5 mg daily versus placebo and spironolactone 25 mg daily versus placebo in ...

twice daily), oral bisoprolol (10 mg/d), oral spironolactone (25 mg/d), and oral dapagliflozin (10 mg/d), as well as intramuscular benzathine penicillin G (1.2 million units every 4 wk) as secondary ...

Each arm was further randomized to receive spironolactone 25 mg daily or placebo. The current data compare the colchicine and matching placebo arms irrespective of spironolactone use. The primary ...